| Current Price | $97.10 | Mkt Cap | $194.7B |
|---|---|---|---|
| Open | $96.94 | P/E Ratio | 27.47 |
| Prev. Close | $85.61 | Div. (Yield) | $2.01 (2.1%) |
| Daily Range | $96.55 - $97.11 | Volume | 383,139 |
| 52-Wk Range | $69.18 - $99.84 | Avg. Daily Vol. | 1,892,926 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
| Current Price | $97.10 | Mkt Cap | $194.7B |
|---|---|---|---|
| Open | $96.94 | P/E Ratio | 27.47 |
| Prev. Close | $85.61 | Div. (Yield) | $2.01 (2.1%) |
| Daily Range | $96.55 - $97.11 | Volume | 383,139 |
| 52-Wk Range | $69.18 - $99.84 | Avg. Daily Vol. | 1,892,926 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
TMFacarchidi
(62.38)
Submitted: 8/14/2020 12:06:04 PM :
Start Price:
$85.01
NYSE:NVS Score:
+0.52
It's the most flexible and versatile of the large pharma companies, and its leadership places tremendous value on scientific effectiveness as well as managerial competence.
Recs
jbswen
(< 20)
Submitted: 3/27/2020 2:10:51 PM :
Start Price:
$79.17
NYSE:NVS Score:
-26.99
With this epidemic and once the find a cure they are for sure to take off
Recs
XMFmarkprvulovic
(< 20)
Submitted: 10/17/2019 4:21:14 AM :
Start Price:
$82.06
NYSE:NVS Score:
-13.92
Growing revenues among most major drugs, with its top therapy seeing an impressive 23% increase in quarterly revenue. Updated clinical results for breast cancer drug are also highly impressive.
Find the members with the highest scoring picks in NVS.
wcwhiner (28.54) Score: +119.95
The Score Leader is the player with the highest score across all their picks in NVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Bankwatcher1 | 26.34 | 10/7/2008 |
|
NS | $38.28 | +153.06% | +271.42% | +118.36 | 0 Comment | |
| Spelunkin | 50.71 | 11/2/2009 |
|
5Y | $38.67 | +150.52% | +267.27% | +116.75 | 0 Comment | |
| PurePwnage | 99.47 | 11/27/2009 |
|
5Y | $41.02 | +136.20% | +252.81% | +116.61 | 0 Comment | |
| 39272x0 | 94.03 | 12/2/2009 |
|
5Y | $42.06 | +130.32% | +243.68% | +113.35 | 0 Comment | |
| kaChingkaChing | 36.09 | 12/2/2009 |
|
3W | $42.06 | +130.32% | +243.68% | +113.35 | 0 Comment | |
| TrackDuality | 24.91 | 11/6/2009 |
|
5Y | $39.09 | +147.84% | +259.91% | +112.07 | 0 Comment | |
| DiamondDawg | 96.55 | 11/25/2009 |
|
5Y | $41.69 | +132.39% | +244.02% | +111.63 | 0 Comment | |
| 39272x4 | 26.30 | 11/10/2009 |
|
5Y | $39.99 | +142.24% | +249.87% | +107.63 | 0 Comment | |
| wcwhiner | 28.54 | 4/28/2009 |
|
NS | $27.73 | +249.39% | +349.43% | +100.03 | 0 Comment | |
| BridgeTech | < 20 | 5/29/2009 |
|
3Y | $29.84 | +224.64% | +322.72% | +98.08 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
